The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

BACKGROUND: Safe and effective vaccines against Ebola could prevent or control outbreaks. The safe use of replication-competent vaccines requires a careful dose-selection process. We report the first safety and immunogenicity results in volunteers receiving 3 × 10(5) plaque-forming units (pfu) of th...

全面介紹

Na minha lista:
書目詳細資料
發表在:Lancet Infect Dis
Main Authors: Huttner, Angela, Dayer, Julie-Anne, Yerly, Sabine, Combescure, Christophe, Auderset, Floriane, Desmeules, Jules, Eickmann, Markus, Finckh, Axel, Goncalves, Ana Rita, Hooper, Jay W, Kaya, Gürkan, Krähling, Verena, Kwilas, Steve, Lemaître, Barbara, Matthey, Alain, Silvera, Peter, Becker, Stephan, Fast, Patricia E, Moorthy, Vasee, Kieny, Marie Paule, Kaiser, Laurent, Siegrist, Claire-Anne
格式: Artigo
語言:Inglês
出版: 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6624136/
https://ncbi.nlm.nih.gov/pubmed/26248510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(15)00154-1
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍